Key facts
| Price (PPV) | 1,493 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | carboplatine |
| Class | Antineoplastic agents |
| ATC code | L01XA02 |
| Manufacturer | PFIZER MAROC |
| Presentation | Flacon de 45 ml |
| Nature | Médicament |
| Hospital price | 1,228 MAD |
| Data collected on | 9/8/2026 |
Indications
En monothérapie ou en association dans le traitement du carcinome ovarien, du carcinome bronchique à petites cellules, de tumeurs au niveau ORL et du cancer du col de l'utérus. Pour les cancers du domaine ORL, la monothérapie devrait être associée à une radiothérapie. En cas de cancer de la vessie, le carboplatine est indiqué uniquement en association avec d'autres cytostatiques.
Find an open pharmacy
On-call pharmacies near you
About Carboplatine Dbl 450 mg / 45 ml
Carboplatine Dbl 450 mg / 45 ml belongs to the antineoplastic agents therapeutic class. In Morocco, this drug is marketed by PFIZER MAROC and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Carboplatine Dbl 450 mg / 45 ml, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Carboplatine Dbl 450 mg / 45 ml
Answers to common questions from Moroccan patients about this drug.